Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 CytokineticsEndo InternationalHomology MedicinesMyovant SciencesStoke Therapeutics
SymbolNASDAQ:CYTKNASDAQ:ENDPNASDAQ:FIXXNYSE:MYOVNASDAQ:STOK
Price Information
Current Price$21.11$3.63$15.93$17.75$25.45
52 Week RangeBuyHoldBuyBuyBuy
Beat the Market™ Rank
Overall Score1.81.51.71.91.2
Analysis Score4.53.14.53.43.5
Community Score3.52.62.62.62.7
Dividend Score0.00.00.00.00.0
Ownership Score1.01.01.03.00.0
Earnings & Valuation Score0.00.60.60.60.0
Analyst Ratings
Consensus RecommendationBuyHoldBuyBuyBuy
Consensus Price Target$26.43$5.72$33.50$27.00$36.50
% Upside from Price Target25.19% upside57.54% upside110.30% upside52.11% upside43.42% upside
Trade Information
Market Cap$1.24 billion$886.66 million$643.84 million$1.10 billion$912.03 million
Beta1.411.55-0.052.56N/A
Average Volume931,0666,148,647348,8121,030,476184,721
Sales & Book Value
Annual Revenue$26.87 million$2.91 billion$1.67 millionN/AN/A
Price / Sales46.720.29431.28N/AN/A
CashflowN/A$4.91 per shareN/AN/AN/A
Price / CashN/A0.74N/AN/AN/A
Book Value($0.19) per share($3.82) per share$5.73 per share($1.21) per share$6.86 per share
Price / Book-111.11-0.952.78N/AN/A
Profitability
Net Income$-121,690,000.00$-422,640,000.00$-103,920,000.00$-288,990,000.00$-32,330,000.00
EPS($2.11)$2.38($2.47)($3.37)($1.80)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/A1.59N/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-592.61%-9.09%-5,816.28%N/AN/A
Return on Equity (ROE)-10,351.99%-91.00%-44.92%-2,288.94%-16.47%
Return on Assets (ROA)-56.54%6.73%-36.71%-172.45%-16.10%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/A5.88%N/A
Current Ratio10.89%2.03%13.66%1.02%39.56%
Quick Ratio10.89%1.79%13.66%1.02%39.56%
Ownership Information
Institutional Ownership Percentage93.71%82.32%81.86%34.22%N/A
Insider Ownership Percentage6.40%2.30%28.00%3.68%N/A
Miscellaneous
Employees1303,1721248644
Shares Outstanding59.47 million229.71 million45.21 million89.87 million32.97 million
Next Earnings Date8/13/2020 (Estimated)8/3/2020 (Estimated)8/13/2020 (Estimated)8/4/2020 (Estimated)8/12/2020 (Estimated)
OptionableOptionableOptionableNot OptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.